- New
-
Topics
- All Categories
- Metaphysics and Epistemology
- Value Theory
- Science, Logic, and Mathematics
- Science, Logic, and Mathematics
- Logic and Philosophy of Logic
- Philosophy of Biology
- Philosophy of Cognitive Science
- Philosophy of Computing and Information
- Philosophy of Mathematics
- Philosophy of Physical Science
- Philosophy of Social Science
- Philosophy of Probability
- General Philosophy of Science
- Philosophy of Science, Misc
- History of Western Philosophy
- Philosophical Traditions
- Philosophy, Misc
- Other Academic Areas
- Journals
- Submit material
- More
The Inherent Unfairness of COVID-19 Drug Access Pathways
American Journal of Bioethics 20 (9):18-20 (2020)
Abstract
Volume 20, Issue 9, September 2020, Page 18-20.Other Versions
No versions found
My notes
Similar books and articles
Adopting an Anti-Racist Model of COVID-19 Drug Allocation and Prioritization.Akilah A. Jefferson - 2020 - American Journal of Bioethics 20 (9):33-36.
Guiding Difficult Decisions on Scarce Investigational Therapeutic Agents in the COVID-19 Pandemic.Keith W. Hamilton - 2020 - American Journal of Bioethics 20 (9):20-23.
No Easy Answers in Allocating Unapproved COVID-19 Drugs Outside Clinical Trials.Jaime Webb, Lesha Shah & Holly Fernandez Lynch - 2020 - American Journal of Bioethics 20 (9):W1-W4.
Ambulance Charters during the COVID-19 Pandemic and Equitable Access to Scarce Resources.Daniel Du Pont & Jill Baren - 2020 - American Journal of Bioethics 20 (10):7-9.
In Response to COVID-19 Pandemic Physicians Already Know What to Do.Laurence B. McCullough - 2020 - American Journal of Bioethics 20 (7):9-12.
What is a Bioethics of the Oppressed in the Age of COVID-19?Craig M. Klugman - 2020 - American Journal of Bioethics 20 (10):29-31.
The Case for Methodological Pluralism in Medical Science.Sarah J. L. Edwards, Thomas Bock, Ulo Palm, Sally Wang, Glen Cheng, Lixia Wang & Peter Pitts - 2020 - American Journal of Bioethics 20 (9):39-41.
The Regulation of COVID-19 “Challenge” Studies.Jerry Menikoff - 2020 - American Journal of Bioethics 20 (7):80-82.
Understanding Corporate Responsibility: Culture and Complicity.Chris Degeling, Cynthia Townley & Wendy Rogers - 2011 - American Journal of Bioethics 11 (9):18-20.
Justice and Guidance for the COVID-19 Pandemic.Rosamond Rhodes - 2020 - American Journal of Bioethics 20 (7):163-166.
Analytics
Added to PP
2020-08-26
Downloads
22 (#982,541)
6 months
2 (#1,694,052)
2020-08-26
Downloads
22 (#982,541)
6 months
2 (#1,694,052)
Historical graph of downloads
Citations of this work
No Easy Answers in Allocating Unapproved COVID-19 Drugs Outside Clinical Trials.Jaime Webb, Lesha Shah & Holly Fernandez Lynch - 2020 - American Journal of Bioethics 20 (9):W1-W4.
Allocation of Opportunities to Participate in Clinical Trials during the Covid‐19 Pandemic and Other Public Health Emergencies.Kayte Spector-Bagdady, Holly Fernandez Lynch, Barbara E. Bierer, Luke Gelinas, Sara Chandros Hull, David Magnus, Michelle N. Meyer, Richard R. Sharp, Jeremy Sugarman, Benjamin S. Wilfond, Ruqaiijah Yearby & Seema Mohapatra - 2021 - Hastings Center Report 52 (1):51-58.
References found in this work
Ethically Allocating COVID-19 Drugs Via Pre-approval Access and Emergency Use Authorization.Jamie Webb, Lesha D. Shah & Holly Fernandez Lynch - 2020 - American Journal of Bioethics 20 (9):4-17.
Clinical Trial Portfolios: A Critical Oversight in Human Research Ethics, Drug Regulation, and Policy.Alex John London & Jonathan Kimmelman - 2019 - Hastings Center Report 49 (4):31-41.
The Critical Role of Medical Institutions in Expanding Access to Investigational Interventions.Kayte Spector-Bagdady, Kevin J. Weatherwax, Misty Gravelin & Andrew G. Shuman - 2019 - Hastings Center Report 49 (2):36-39.
PhilPapers logo by Andrea Andrews and Meghan Driscoll.
This site uses cookies and Google Analytics (see our terms & conditions for details regarding the privacy implications). Use of this site is subject to terms & conditions.
All rights reserved by The PhilPapers Foundation
Server: philpapers-web-648784bb4d-xlp8h uwo